Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 338-347

  Sternberg, Zohara ^a   Ghanim, Husam ^a   Gillotti, Kristen M ^b   Tario, Joseph D ^b   Munschauer, Frederick ^a   Curl, Richard ^a   Noor, Sonya ^a   Yu, Jihnhee ^c   Ambrus, Julian L ^a   Wallace, Paul ^b   Dandona, Paresh ^a  

^a Kaleida Medical Center   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Carotid stenosis; Cell adhesion; Cell surface markers; Gene expression; Immunophenotyping; Mononuclear cells; Thrombosis

Indexed keywords

GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; JANUS KINASE 1; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE ANTIGEN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR PAI 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE ACTIVATION; MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ATF; ATRIAL FIBRILLATION; BLOOD PRESSURE; BMI; BODY MASS INDEX; BP; CAD; CARDIOVASCULAR; CAROTID DISEASE PATIENTS; CAROTID ENDARTERECTOMY; CAROTID STENOSIS; CDP; CEA; CELL ADHESION; CELL SURFACE MARKERS; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; CV; CVD; DIABETES MELLITUS; DM; EARLY GROWTH RESPONSE; EGR; ERK; EXTRACELLULAR REGULATED KINASE; GENE EXPRESSION; HC; HEALTHY CONTROL; HEART FAILURE; HF; HIGH-MOBILITY GROUP PROTEIN B; HMGB; IMMUNOPHENOTYPING; JNK; JUN N-TERMINAL KINASE; MAGNETIC RESONANCE ANGIOGRAPHY; MAMMALIAN TARGET OF RAPAMYCIN; MAP; MATRIX METALLOPROTEINASE; MCP; MITOGEN ACTIVATED PROTEIN; MMP; MNC; MONOCYTE CHEMOTACTIC PROTEIN; MONONUCLEAR CELL; MONONUCLEAR CELLS; MRA; MTOR; NF-KB; NUCLEAR FACTOR KAPPA B; P; PAD; PAI; PERIPHERAL; PERIPHERAL ARTERIAL DISEASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PHOTOMULTIPLER TUBE; PLASMINOGEN ACTIVATOR INHIBITOR; PMT; PPAR; TF; TGF; THROMBOSIS; TISSUE FACTOR; TLR; TNF; TOLL-LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE; VCAM;

AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CAROTID STENOSIS; CELL ADHESION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES; THROMBOSIS; TRANSCRIPTOME; VASCULITIS;

EID: 84880402677     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.035     Document Type: Article

References (49)

1. Abe Y., Sakaguchi M., Furukado S., et al. Interleukin-6 release after carotid artery stenting and periprocedural new ischemic lesions. JCereb Blood Flow Metab 2010, 30:857-863.
2. Arai M., Uchiba M., Komura H., Mizuochi Y., Harada N., Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes invitro. JPharmacol Exp Ther 2010, 334:206-213.
3. Ciccone M.M., Marzullo A., Mizio D., et al. Can carotid plaque histology selectively predict the risk of an acute coronary syndrome?. Int Heart J 2011, 52:72-77.
4. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. Tlymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1995, 92:3893-3897.
5. Park J.S., Gamboni-Robertson F., He Q., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006, 290:C917-C924.
6. van Zoelen M.A., Yang H., Florquin S., et al. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation invivo. Shock 2009, 31:280-284.
7. Chavez-Sanchez L., Madrid-Miller A., Chavez-Rueda K., Legorreta-Haquet M.V., Tesoro-Cruz E., Blanco-Favela F. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Hum Immunol 2010, 71:737-744.
8. Scholtes V.P., Versteeg D., de Vries J.P., et al. Toll-like receptor 2 and 4 stimulation elicits an enhanced inflammatory response in human obese patients with atherosclerosis. Clin Sci (Lond) 2011, 121:205-214.
9. Monaco C., Gregan S.M., Navin T.J., Foxwell B.M., Davies A.H., Feldmann M. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 2009, 120:2462-2469.
10. Branen L., Hovgaard L., Nitulescu M., Bengtsson E., Nilsson J., Jovinge S. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2004, 24:2137-2142.
11. Ohta H., Wada H., Niwa T., et al. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005, 180:11-17.
12. Lorne E., Zhao X., Zmijewski J.W., et al. Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol 2009, 41:237-245.
13. Caligiuri G., Nicoletti A., Poirier B., Hansson G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. JClin Invest 2002, 109:745-753.
14. Ait-Oufella H., Herbin O., Bouaziz J.D., et al. Bcell depletion reduces the development of atherosclerosis in mice. JExp Med 2010, 207:1579-1587.
15. Frostegard J., Ulfgren A.K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145:33-43.
16. Feinberg M.W., Shimizu K., Lebedeva M., et al. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation. Circ Res 2004, 94:601-608.
17. Straus D.S., Glass C.K. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007, 28:551-558.
18. Wang P., Anderson P.O., Chen S., Paulsson K.M., Sjogren H.O., Li S. Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands. Int Immunopharmacol 2001, 1:803-812.
19. von Knethen A., Soller M., Tzieply N., et al. PPARgamma1 attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/macrophages. JCell Biol 2007, 176:681-694.
20. Di Taranto M.D., Morgante A., Bracale U.M., et al. Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. Atherosclerosis 2012, 220:93-101.
21. Puig O., Yuan J., Stepaniants S., et al. Agene expression signature that classifies human atherosclerotic plaque by relative inflammation status. Circ Cardiovasc Genet 2011, 4:595-604.
22. Pitocco D., Giubilato S., Zaccardi F., et al. Pioglitazone reduces monocyte activation in type 2 diabetes. Acta Diabetol 2009, 46:75-77.
23. Tziakas D.N., Lazarides M.K., Tentes I.K., et al. Gelatinases [matrix metalloproteinase-2 (MMP-2) and MMP-9] induce carotid plaque instability but their systemic levels are not predictive of local events. Ann Vasc Surg 2005, 19:529-533.
24. Westfall P., Young S.S. Resampling-based multiple testing: examples and methods for P-value adjustment 1993, Wiley, NY.
25. Bonanno E., Mauriello A., Partenzi A., Anemona L., Spagnoli L.G. Flow cytometry analysis of atherosclerotic plaque cells from human carotids: a validation study. Cytometry 2000, 39:158-165.
26. Businaro R., Digregorio M., Rigano R., et al. Morphological analysis of cell subpopulations within carotid atherosclerotic plaques. Ital J Anat Embryol 2005, 110:109-115.
27. Ichiki T., Jougasaki M., Setoguchi M., et al. Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells. Am J Physiol Heart Circ Physiol 2008, 294:H750-H763.
28. Miura S., Matsuo Y., Kawamura A., Saku K. JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways. Atherosclerosis 2005, 182:267-275.
29. Rigamonti E., Fontaine C., Lefebvre B., et al. Induction of CXCR2 receptor by peroxisome proliferator-activated receptor gamma in human macrophages. Arterioscler Thromb Vasc Biol 2008, 28:932-939.
30. Bitto A., De Caridi G., Polito F., et al. Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. JVasc Surg 2010, 52:1015-1021.
31. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-342.
32. Chen K.B., Uchida K., Nakajima H., et al. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats. Spine (Phila Pa 1976) 2011, 36:2122-2129.
33. Porto A., Palumbo R., Pieroni M., et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006, 20:2565-2566.
34. Morris-Rosenfeld S., Blessing E., Preusch M.R., et al. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Eur J Clin Invest 2011, 41:1164-1171.
35. Takahashi K., Takeya M., Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 2002, 35:179-203.
36. Madej A., Buldak L., Basiak M., Szkrobka W., Dulawa A., Okopien B. The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the exvivo ability of monocytes to secrete inflammatory cytokines. Int J Clin Pharmacol Ther 2009, 47:686-694.
37. Bu D.X., Griffin G., Lichtman A.H. Mechanisms for the anti-inflammatory effects of statins. Curr Opin Lipidol 2011, 22:165-170.
38. Muhlestein J.B. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost 2010, 103:71-82.
39. Bogdanski P., Pupek-Musialik D., Dytfeld J., et al. Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther 2007, 45:563-567.
40. Koutouzis M., Paraskevas K.I., Rallidis L.S., et al. Statin treatment, carotid atherosclerotic plaque macrophage infiltration and circulating inflammatory markers. Open Cardiovasc Med J 2008, 2:110-114.
41. Erbel C., Dengler T.J., Wangler S., et al. Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol 2011, 106:125-134.
42. Yarwood H., Mason J.C., Mahiouz D., Sugars K., Haskard D.O. Resting and activated T cells induce expression of E-selectin and VCAM-1 by vascular endothelial cells through a contact-dependent but CD40 ligand-independent mechanism. JLeukoc Biol 2000, 68:233-242.
43. Schulte S., Sukhova G.K., Libby P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am J Pathol 2008, 172:1500-1508.
44. Jongstra-Bilen J., Haidari M., Zhu S.N., Chen M., Guha D., Cybulsky M.I. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. JExp Med 2006, 203:2073-2083.
45. Taleb S., Tedgui A., Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. JIntern Med 2008, 263:489-499.
46. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
47. Weber C., Belge K.U., von Hundelshausen P., et al. Differential chemokine receptor expression and function in human monocyte subpopulations. JLeukoc Biol 2000, 67:699-704.
48. Kyaw T., Tay C., Khan A., et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. JImmunol 2010, 185:4410-4419.
49. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009, 27:165-197.